MYTHS - MYocarditis THerapy With Steroids

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 288 participants.

Also called NCT05150704

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 288 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05150704
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Austria, Belgium, Czechia, Finland, Italy, Slovenia, Spain, Sweden (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05150704. Randomized; single masking; primary purpose treatment. Start 2021-10-07 (actual); primary completion 2028-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
MYTHS - MYocarditis THerapy With Steroids
Acronym
MYTHS
Condition
Myocarditis Acute
Intervention (Drug)
Methylprednisolone
Intervention (Drug)
saline solution
Lead sponsor
Niguarda Hospital (class: other)
Collaborator
Ministry of Health, Italy (class: other government)
Collaborator
Istituto Di Ricerche Farmacologiche Mario Negri (class: other)
Collaborator
University of Milano Bicocca (class: other)
Collaborator
Regione Lombardia (class: other)

Record details

Record id
cardio:ct-nct05150704
Content hash
2c7ad403eb6da3810f0ac07732ece1eb6712ad02fe3ba978267da0185e04d50d